Skip to content

The evaluation of safety and sedative efficacy of alfentanil-midazolam combination in fiberoptic bronchoscopy

The evaluation of safety and sedative efficacy of alfentanil-midazolam combination in fiberoptic bronchoscopy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100049052
Enrollment
Unknown
Registered
2021-07-20
Start date
2021-09-30
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intraoperative sedation

Interventions

midazolam-alfentanil combination group:alfentanil and midazolam intravenous bolus
midazolam-fentanyl combination group:fentanyl and midazolam intravenous bolus

Sponsors

Beilun People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Clinical patients who agree to participate in the research program; 2. Have clear indications for fiberoptic bronchoscopy; 3. Aged 18 to 60 years old.

Exclusion criteria

Exclusion criteria: 1. Perennial alcohol addiction, long-term use of drugs that affect mental state (such as sedatives) and monoamine oxidase inhibitors; 2. Combined with severe liver dysfunction (Child-Pugh class C); renal dysfunction (dialysis before surgery); 3. Combined mental and psychological disorders lead to impaired cognitive function; 4. Patients with bronchial asthma, respiratory depression, myasthenia gravis and high sensitivity; 5. Pregnant women; 6. Aged over 60 years old, or less than 18 years old; 7. Arrhythmia, preoperative left ventricular ejection fraction less than 30%, sick sinus syndrome, severe sinus bradycardia (< 50 beats/min) or second degree and above atrioventricular block, pacing is installed device.

Design outcomes

Primary

MeasureTime frame
heart rate;biood pressure;oxygen saturation of blood;Ramsay sedation score;VAS score of cough response;

Countries

China

Contacts

Public ContactCao Yunfei

Beilun People's Hospital

caoyunfeicn@sina.com+86 13505886675

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026